Jubilant Life falls 6% as USFDA recommends action on failing inspection

The stock dipped 6% to Rs 742 on the BSE after the US health regulator recommended a regulatory or administrative action after the inspection of the drug firm's Roorkee manufacturing facility.

from Latest News https://ift.tt/2Edo3rc

Facebook Google Twitter More

• Pinterest
• Linkedin
• Tumblr

Posted by : Camera Guru 1:33 pm Tags : Latest News

Subscribe by Email

Follow Updates Articles from This Blog via Email